120 related articles for article (PubMed ID: 29113829)
21. IGF-I prevents glutamate-induced motor neuron programmed cell death.
Vincent AM; Mobley BC; Hiller A; Feldman EL
Neurobiol Dis; 2004 Jul; 16(2):407-16. PubMed ID: 15193297
[TBL] [Abstract][Full Text] [Related]
22. Prevention by insulin-like growth factor-I and riluzole in motor neuron death after neonatal axotomy.
Iwasaki Y; Ikeda K
J Neurol Sci; 1999 Oct; 169(1-2):148-55. PubMed ID: 10540024
[TBL] [Abstract][Full Text] [Related]
23. Calbindin-D28K is increased in the ventral horn of spinal cord by neuroprotective factors for motor neurons.
Spruill MM; Kuncl RW
J Neurosci Res; 2015 Aug; 93(8):1184-91. PubMed ID: 25914366
[TBL] [Abstract][Full Text] [Related]
24. Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice.
Narai H; Nagano I; Ilieva H; Shiote M; Nagata T; Hayashi T; Shoji M; Abe K
J Neurosci Res; 2005 Nov; 82(4):452-7. PubMed ID: 16235250
[TBL] [Abstract][Full Text] [Related]
25. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
26. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis.
Nagano I; Ilieva H; Shiote M; Murakami T; Yokoyama M; Shoji M; Abe K
J Neurol Sci; 2005 Aug; 235(1-2):61-8. PubMed ID: 15990113
[TBL] [Abstract][Full Text] [Related]
28. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
29. Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity.
Saenger S; Holtmann B; Nilges MR; Schroeder S; Hoeflich A; Kletzl H; Spooren W; Ostrowitzki S; Hanania T; Sendtner M; Metzger F
Amyotroph Lateral Scler; 2012 Sep; 13(5):418-29. PubMed ID: 22871074
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
31. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
[TBL] [Abstract][Full Text] [Related]
33. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
34. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
35. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
36. Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons.
Bilak MM; Corse AM; Kuncl RW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Jun; 2(2):83-91. PubMed ID: 11675876
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
38. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death.
Ranno E; D'Antoni S; Spatuzza M; Berretta A; Laureanti F; Bonaccorso CM; Pellitteri R; Longone P; Spalloni A; Iyer AM; Aronica E; Catania MV
Neurobiol Dis; 2014 May; 65():160-71. PubMed ID: 24423643
[TBL] [Abstract][Full Text] [Related]
39. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
40. Brain-Derived Neurotrophic Factor Facilitates Functional Recovery from ALS-Cerebral Spinal Fluid-Induced Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line.
Shruthi S; Sumitha R; Varghese AM; Ashok S; Chandrasekhar Sagar BK; Sathyaprabha TN; Nalini A; Kramer BW; Raju TR; Vijayalakshmi K; Alladi PA
Neurodegener Dis; 2017; 17(1):44-58. PubMed ID: 27617773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
